polychemotherapy


Also found in: Acronyms.

polychemotherapy

 [pol″e-ke″mo-ther´ah-pe]
chemotherapy involving simultaneous administration of several agents.

polychemotherapy

(pŏl″ē-kē″mō-thĕr′ă-pē) [″ + chemeia, chemistry, + therapeia, treatment]
Treatment with several chemotherapeutic agents at once.
References in periodicals archive ?
Treatment with polychemotherapy was initiated after concluding that the patient had an unresectable cancer.
[12] 70/M + -- *At PTCL-NOS diagnosis; LN: lymph node; BM: bone marrow; PCT: polychemotherapy; RT: radiotherapy; IL-4: interleukin 4; NA: not available; ND: not done; PTCL-NOS: peripheral T-cell lymphoma not otherwise specified; CLL/SLL: chronic lymphocytic leukemia/small lymphocytic lymphoma; TIA1: T-cell intracellular antigen-1.
Gisslinger, "Marked and sustained improvement of systemic sclerosis following polychemotherapy for coexistent multiple myeloma," Clinical and Experimental Rheumatology, vol.
This suggests the need for an early diagnosis when the patient's performance status still permits the administration of polychemotherapy regimens burdened by great toxicity.
Although modern polychemotherapy has significantly improved Hodgkin lymphoma (HL) survival rates, relapsed and refractory HL have still poor prognosis [1].
Steck, "Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy," European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.
Patient treatment cards of all patients on polychemotherapy (PCT) who started treatment between 01.01.2013 and 31.12.2014 were studied.
The first group of premenarchal patients aged from 3 to 7.5 years undergoing polychemotherapy without GnRH analogs; the age of the second group of postmenarche women who received GnRH analogs before polychemotherapy was 14.7-20 years; the third group were postmenarchal patients aged 15.9 to 20 years who received polychemotherapy without GnRH analog.
Complete hematologic remission and efficiency of fluid depletion therapy allowed the second course of polychemotherapy after which the patient developed an acute hepatitis C.
Transurethral resection [24] of bladder tumour (Burkitt's lymphoma) plus subsequent antiretroviral treatment with stavudine (40 mg twice daily), lamivudine (150 mg twice daily), and nelfinavir (750 mg 3 8 months of times daily), as well followup as antitumour polychemotherapy (4 cycles of cyclophosphamide, vincristine, doxorubicin, and dexamethasone, alternated with 4 cycles of methotrexate and cytarabine) Tsiriopoulos Cystectomy and ileal Details are not et al.